relative to prescribing ibogaine for investigational use only and adopting the physician associate licensure compact.

Summary

The law authorizes New Hampshire to take part in a partnership that will run FDA‑overseen clinical trials of ibogaine, a drug being studied for opioid addiction and other brain conditions. The state will provide a modest grant, set up dedicated funds for the research and any resulting intellectual‑property revenue, and require regular reporting to the legislature.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share